Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxifloxacin in Pediatric Complicated Intra-abdominal Infection
NCT01069900Phase 3Completed
- Sponsor
- Bayer
- Start
- Jul 2010
- Primary completion
- Jan 2015
- Modality
- Orthosteric Ligands
- Countries
- 16
01
Overview
A Phase 3 trial of moxifloxacin in Intra-abdominal infection (IAI), sponsored by Bayer. Started Jul 2010; status: completed.
02
Drugs
moxifloxacin
03
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on NCT01069900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01069900.